|Year : 2019 | Volume
| Issue : 3 | Page : 307-312
Hearing loss among hypertensive patients
Stephen S Yikawe1, Samuel U Uguru2, Joseph H Solomon1, Andrew M Adamu3, Frederick Damtong4, Kingsley Osisi1, Foluso M Adeyeye1
1 Department of ENT, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria
2 Cardiology Unit, Department of Internal Medicine, Jos University Teaching Hospital, Jos, Nigeria
3 Department of Veterinary Public Health and Preventive Medicine, University of Abuja, Nigeria
4 Department of ENT, University of Abuja Teaching Hospital, Abuja, Nigeria
|Date of Submission||13-Feb-2019|
|Date of Acceptance||17-Jun-2019|
|Date of Web Publication||21-Aug-2019|
MBBS, MPH, FWACS Stephen S Yikawe
Department of ENT, Usmanu Danfodiyo University Teaching Hospital, No. 1 Garba Nadama Road, Gawon Nama Area, Sokoto, 840232
Source of Support: None, Conflict of Interest: None
Background Hypertension is a leading cause of mortality and morbidity worldwide. Hypertensives have been observed to have elevated hearing thresholds in various studies.
Aims and objectives The aims of this study were to assess the hearing thresholds of hypertensives in a tertiary hospital in Nigeria and compare it with nonhypertensive controls.
Patients and methods This was a cross-sectional study conducted among hypertensives and age-matched and sex-matched controls from August 2015 to April 2016. A pretested questionnaire was used to obtain information on demographic and medical history. General physical examination and blood pressure measurements were done. Hearing thresholds were then measured with a diagnostic pure tone audiometer.
Data analysis The pure tone average was calculated. Data analysis was done using the Statistical Package for Social Sciences, version 23.
Results A total number of 104 participants were enrolled into the study. Fifty-two were hypertensives while the other 52 were nonhypertensive controls. The mean age of the participants was 49.1±10.3 years, with ages ranging from 34 to 85 years. There were 38 (36.5%) women and 66 (63.5%) men. Among the hypertensive participants, 20 (38.5%) had various degrees of hearing loss, whereas seven (13.5%) of the non-hypertensives had hearing loss (P=0.004, χ2=8.45). The mean pure tone average (air conduction) among the hypertensive participants was 27.8±13.3 dB HL and 16.7±7.9 dB HL among the nonhypertensive control group. Among the hypertensives, 17 (32.7%) had mild hearing loss, while all seven (13.5%) patients in the nonhypertensive group had mild hearing loss.
Conclusion This study has observed a 38.5% prevalence of hearing loss among hypertensives. It has shown an association between hypertension and hearing thresholds. All frequencies tested were observed to have elevated hearing thresholds among hypertensives as compared with the nonhypertensive control group.
Keywords: hearing loss, hypertension, pure tone audiometry
|How to cite this article:|
Yikawe SS, Uguru SU, Solomon JH, Adamu AM, Damtong F, Osisi K, Adeyeye FM. Hearing loss among hypertensive patients. Egypt J Otolaryngol 2019;35:307-12
|How to cite this URL:|
Yikawe SS, Uguru SU, Solomon JH, Adamu AM, Damtong F, Osisi K, Adeyeye FM. Hearing loss among hypertensive patients. Egypt J Otolaryngol [serial online] 2019 [cited 2019 Dec 7];35:307-12. Available from: http://www.ejo.eg.net/text.asp?2019/35/3/307/264998
| Introduction|| |
Hypertension is a leading cause of morbidity and mortality worldwide ,. A worldwide prevalence of 40% among adults aged 25 years and above was reported by the WHO in 2008 . Two-thirds of the burden of hypertension is in the middle-income and low-income countries , with Africa having the highest prevalence of 46% . Hypertension affects various systems in the body. It has been observed to contribute to the global burden of heart, kidney, and cerebrovascular disease . Complications of hypertension account for 9.4 million deaths worldwide every year ,. In Nigeria the prevalence of hypertension ranged from 9.3 to 50% in various studies conducted across the six geopolitical zones of the country .
Hearing loss is a hidden disability affecting about 360 million people worldwide based on WHO estimates ,. The greatest burden of disabling hearing loss is also in low-income and middle-income countries, the worst hit regions being sub-Saharan Africa and Asia . It is estimated that 50% of cases of hearing loss are preventable through prevention of exposure to risk factors, and prompt treatment of disease conditions that affect the hearing threshold of individuals . Hearing loss may cause isolation, depression, irritability, low self-esteem, and an overall reduction in the quality of life of individuals who are affected .
The association between hearing loss and hypertension is still being debated. Some authors have observed greater hearing deficits among hypertensives ,,,,, while others have not observed any association between hearing loss and hypertension ,. Hearing loss and noise exposure has been observed to cause hypertension in another study . Several mechanisms leading to hearing loss among hypertensives have been hypothesized. Hypertension causes increased blood viscosity, leading to reduced blood flow through capillaries, and tissue hypoxia ,. Another mechanism postulated is ionic changes in the cochlea leading to hearing loss . Inhibition of the potassium pump in the stria vascularis, stops potassium influx to hair cells stopping depolarization . The cochlear which is supplied by end arteries is adversely affected by any pathology that compromises the caliber of its blood vessels. This affects the supply of oxygen and nutrients. Hypertension, which predisposes to atherosclerosis, compromises the caliber of blood vessels ,. Other authors have suggested that high systemic blood pressure causes hemorrhage within the cochlear, thereby compromising hearing . Nigeria being the most populous black nation contributes significantly to the overall burden of hypertension and its complications in Africa. We have not identified any published work on hypertension and hearing loss in Nigeria. This study attempts to assess the hearing thresholds of hypertensives in a tertiary hospital in Nigeria and compare it with nonhypertensive controls.
| Patients and methods|| |
This was a cross-sectional study conducted among hypertensives and an equal number of age-matched and sex-matched nonhypertensive controls attending the medical clinics of a tertiary health center, between August 2015 and April 2016. Institutional ethical approval was obtained and informed consent was taken from the participants before they were recruited into the study.
The inclusion criterion for the study group was physician-diagnosed hypertensives attending the medical clinics of the hospital for at least a year. Inclusion criterion for the control group was non-hypertensive adults (as evidenced by a normal blood pressure of <140/90 mmHg) attending the medical clinics of the hospital. Exclusion criteria included participants with a history of ear surgery performed in the past, history of exposure to loud sounds, history of cigarette smoking, history of use of ototoxic drugs, history of ear disease, patients being treated for any medical condition that may cause hearing loss, and an air-bone gap of equal to or greater than 10 dB. The participants were randomly selected to participate in the study.
Blood pressure measurement and medical history
A pretested interviewer-administered questionnaire was used to obtain information about the participants’ biodata and medical history. Participants had general physical examination (including weight, height measurements). Blood pressure was measured on two occasions in the sitting position using a standard mercury sphygmomanometer (Accoson, Accoson North Ayrshire, UK) with an adult cuff size. The patient was seated on a chair with the back rested (not leaning forward), arm on the table, and both feet on the ground. Korotkoff sounds phases I and V were considered as the systolic and diastolic blood pressures, respectively, and recorded in mmHg. This was done after a 5-min rest using the right and left upper limbs. Two additional recordings were made using the limb with the higher value. The average was then calculated to give a representative value of the patient’s blood pressure.
Pure tone audiometry
Both ears of the participants were examined (any obstructing wax observed during otoscopy was removed, after softening). Hearing thresholds were then measured in both ears using the Modified Hughson–Westlake method  at 250, 500, 1000, 2000, 4000, 6000, and 8000 Hz for air conduction and 500, 1000, 2000, and 4000 Hz for bone conduction using a Diagnostic Audiometer (Oscilla SM 960-D, Diagnostic Memory Audiometer, Otometrics, Taastrup, Denmark) in a sound isolated room, which satisfied the criteria of ISO 8253-1. Average of audiometric hearing thresholds at 500, 1000, 2000, and 4000 Hz for both air and bone conduction was determined, which was taken to be the pure tone average for both air and bone conduction. This was categorized in accordance to the WHO grades of hearing impairment as follows: normal hearing (<25 dB), mild hearing loss (26–40 dB), moderate hearing loss (41–60 dB), severe hearing loss (61–80 dB), and profound hearing loss (≥81 dB) . The hearing thresholds for the better ear was used for further analysis in both patient and control groups.
Data analysis was done using the Statistical Package for the Social Sciences, version 23 (IBM − SPSS Inc., Chicago, Illinois, USA). The χ2-test was used to determine the relationship between categorical variables and t-test was used to determine the relationship between quantitative variables. Linear regression was done to test for the association between variables. Data were presented using tables and charts. The level of significance was set at a P value of less than 0.05.
| Results|| |
A total number of 104 participants were enrolled into the study. Fifty-two were hypertensives while the other 52 were nonhypertensive controls. The mean age of the participants was 49.1±10.3 years, with ages ranging from 34 to 85 years. There were 38 (36.5%) women and 66 (63.5%) men. There was no statistically significant difference in age and sex of the two groups ([Table 1] and [Table 2]).
Among the hypertensive participants, 20 (38.5%) had various degrees of hearing loss, whereas seven (13.5%) of the non-hypertensives had hearing loss (P=0.004, χ2=8.45). The mean pure tone average (air conduction) in the better ear among the hypertensive participants was 27.8±13.3 dB HL, and 16.7±7.9 dB HL among the nonhypertensive control group ([Table 3]). All hypertensive patients enrolled in this study were on antihypertensive medication.
Among the hypertensives, 17 (32.7%) had mild hearing loss, whereas all seven (13.5%) patients in the nonhypertensive group had mild hearing loss ([Table 4]). Hearing thresholds increased across the frequencies tested ([Figure 1]).
|Figure 1 Mean hearing thresholds across tested frequencies among participants.|
Click here to view
Regression analysis (with mean hearing threshold as the dependent variable, and presence of hypertension as the independent variable) showed that the presence of hypertension was positively associated with hearing loss (P=0.000). The presence of hypertension in a patient increases the pure tone average by 10.0 dB HL from this data. The data also shows that 17.9% of the variability of hearing threshold is due to hypertension alone.
Systolic blood pressure was found to be associated with pure tone average in this study (P=0.000), and for every 1 mmHg rise in systolic blood pressure, a 0.29 dB increase in hearing threshold is expected. Regression analysis also shows that 13.7% of the variability of pure tone average is due to changes in systolic blood pressure ([Table 5]).
|Table 5 Simple linear regression analysis of systolic blood pressure and pure tone average|
Click here to view
| Discussion|| |
This study observed a 38.5% prevalence of hearing loss among hypertensives. We observed an association between hearing threshold and hypertension, following regression analysis (P<0.05). Agarwal et al.  in a case–control study of hearing loss among hypertensives carried out among hypertensives and a control group observed a 36.7% prevalence of hearing loss among the participants with grade I hypertension. They observed a progressively higher prevalence, with increase in the grade of hypertension . Their study also found a statistically significant association between hypertension and hearing loss . Their observations agree with the findings in this study. A higher prevalence of hearing loss among hypertensives (61%) was however observed by Marchiori et al. . They found hypertension to be an independent risk factor for hearing loss after multivariate analysis .
We found the mean hearing threshold among hypertensives to be 27.8±13.3 dB HL, with elevated mean hearing thresholds across all frequencies tested. Tan et al. , in a cross-sectional study in a University Medical Centre in Malaysia observed that mean hearing thresholds were higher in all frequencies tested on both sides among hypertensives compared with the control group. They found these differences to be significant at 2 kHz and above . Their findings were similar to the findings in this study. The study by Tan and colleagues was among hypertensives with features of hypertensive retinopathy. They found a strong relationship between hypertension and hearing loss among those participants with hypertensive retinopathy . Esparza et al.  in a study on hypertension and inner ear dysfunction among 42 participants also observed that participants with hypertension showed deterioration of hearing thresholds at high frequencies further corroborating the findings in this study. They also found that the degree of retinal vascular compromise correlated with the hearing threshold at 8 kHz . Similar microangiopathic pathological processes is believed to affect both the retina and the cochlea, and as such patients referred for evaluation of their eyes ought to also be sent for auditory evaluation. Other studies among hypertensives have also observed elevated hearing thresholds at higher frequencies ,.
Mild hearing loss was the most common degree of hearing loss in this study. This agrees with the findings in a study conducted among 154 hypertensives and equal number of controls . They found mild hearing loss to be the most common degree of hearing loss observed among hypertensives . Agarwal et al.  also observed mild hearing loss to be the most commonly observed degree of hearing loss. Mondelli and Lopes  in a retrospective study on the relation between arterial hypertension and hearing loss observed among participants with hearing impairment and hypertension, a 13.34% prevalence of mild hearing loss, 56.66% prevalence of moderate hearing loss, and 16.67% prevalence of severe hearing loss. This is in disagreement with the findings in this study. Mild hearing loss is often overlooked or not detected by patients. They are only likely to self-report and thus leave records for a retrospective review when their hearing acuity starts to deteriorate beyond the mild degree.
The mean systolic blood pressure among hypertensives in this study was 142.7±10.3 mmHg. Systolic blood pressure was observed to be positively associated with hearing threshold in this study (P=0.000). Gates et al.  in a study on the relation of hearing in the elderly to cardiovascular disease and risk factors found systolic blood pressure to be related to hearing loss among women. They did not observe any relationship between systolic blood pressure and hearing loss among men nor diastolic blood pressure and hearing loss among both men and women .While this study investigates the effect of hypertension on hearing thresholds, other authors have reported a relationship between hypertension and hearing loss, but with hearing loss being a risk factor for hypertension ,,. Narlawar et al.  in a study among 770 workers in an iron and steel company in India observed that hearing loss and hypertension were common among workers exposed to noise, with hypertension being a likely cause of hearing loss. Chang et al. , in a cross-sectional study of 790 participants, studied the effect of hearing loss on hypertension, and observed a higher prevalence of hypertension among participants with hearing loss.
Other authors however have not observed any relationship between hypertension and hearing loss ,,. Baraldi et al.  studied hearing loss and hypertension among 70 elderly individuals in Sao Paulo and observed no difference in hearing thresholds of the study and control groups. They selected participants whose blood pressure has been controlled. This might have affected their results. In a prospective study of cardiovascular risk factors and hearing loss among 3488 men, hypertension was not significantly associated with the risk of hearing loss . Torre et al.  in a study of cardiovascular disease and cochlear function in older participants did not observe any association between hypertension and cochlear impairment. Both studies were on multifactorial risk factors (hypertension, diabetes mellitus, BMI, dyslipidemia, and cigarette smoking). This may have not allowed the effect of hypertension to be independently assessed as it was done in this study. The limitation of our research is the fact that it is not a population-based study. However, this can serve as a pilot study for a bigger population-based study.
| Conclusion|| |
This study has observed a 38.5% prevalence of hearing loss among hypertensives. It has shown an association between hypertension and hearing loss. All frequencies tested were observed to have elevated hearing thresholds among hypertensives as compared with normal thresholds in the control group. Mild hearing loss was the most common degree of hearing loss observed. We recommend regular audiologic assessment for hypertensive patients.
The authors acknowledge the support given to them by the management and staff of Usmanu Danfodiyo University Teaching Hospital, Sokoto.
S.S. Yikawe: Concept, design, data collection and statistical analysis, manuscript review, and served as the Guarantor of the research. S.U. Uguru: Design, definition of intellectual concept, literature search and clinical studies and manuscript review. J.H. Solomon: Concept, design, data acquisition, literature search, manuscript preparation, review, and editing. A.M. Adamu: Literature search, statistical analysis, manuscript editing, and review. 5F. Damtong: Design, definition of intellectual concept, literature search, and manuscript review. K. Osisi: Concept, literature search, data acquisition, manuscript editing, and review. F.M. Adeyeye: Literature search, clinical studies, data acquisition, manuscript preparation, and review.
This manuscript has been read and approved by all the authors. The requirements for authorship has been met, and all the authors believe that this manuscript represents honest work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217–223.
Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep 2013; 15:134–136.
Mathers C, Fat DM, Boerma JT. The global burden of disease: 2004 update. Geneva: World Health Organization 2008.
Adeloye D, Basquill C, Aderemi A, Thompson J, Obi F. An estimate of the prevalence of hypertension in Nigeria. J Hypertens 2015; 33:230–242.
Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005; 4:2.
Bright T, Pallawela D. Validated smartphone-based apps for ear and hearing assessments: a review. JMIR Rehabil Assist Technol 2016; 3:e13.
Stevens G, Flaxman S, Brunskill E, Mascarenhas M, Mathers C, Finucane M. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Pub Health 2011; 23:146–152.
Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ 2014; 92:367–373.
Kochkin S, Rogin CM. Quantifying the obvious: the impact of hearing instruments on quality of life. Hear Rev 2000; 7:6–34.
Rosenhall U, Sundh V. Age-related hearing loss and blood pressure. Noise Health 2006; 8:88–94.
] [Full text]
Pillsbury HC. Hypertension, hyperlipoproteinemia, chronic noise exposure: is there synergism in cochlear pathology?. Laryngoscope 1986; 96:1112–1138.
Agarwal S, Mishra A, Jagade M, Kasbekar V, Nagle SK. Effects of hypertension on hearing. Indian J Otolaryngol Head Neck Surg 2013; 65:614–618.
Tan TY, Rahmat O, Prepageran N, Fauzi A, Noran NH, Raman R. Hypertensive retinopathy and sensorineural hearing loss. Indian J Otolaryngol Head Neck Surg 2009; 61:275–279.
Mondelli MF, Lopes AC. Relation between arterial hypertension and hearing loss. Arq Int Otorrinolaringol 2009; 13:63–68.
Torre P, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. The association between cardiovascular disease and cochlear function in older adults. J Speech Lang Hear Res 2005; 48:473–481.
Baraldi GS, Almeida LC, Borges AC. Hearing loss and hypertension: findings in an older by group. Rev Bras Otorrinolaringol 2004; 70:640–644.
Chang TY, Liu CS, Huang KH, Chen RY, Lai JS, Bao BY. High-frequency hearing loss, occupational noise exposure and hypertension: a cross-sectional study in male workers. Environ Health 2011; 10:35.
Przewoźny T, Gójska-Grymajło A, Kwarciany M, Gąsecki D, Narkiewicz K. Hypertension and cochlear hearing loss. Blood pressure 2015; 24:199–205.
Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME et al.
Impaired tissue perfusion. Circulation 2008; 118:968–976.
Zdebik AA, Wangemann P, Jentsch TJ. Potassium ion movement in the inner ear: insights from genetic disease and mouse models. Physiology 2009; 24:307–316.
Bhargava M, Ikram MK, Wong TY. How does hypertension affect your eyes?. J Hum Hypertens 2012; 26:71–83.
Arlinger S. Psychoacoustic audiometry. In: Gleeson M, Browning GG, Burton MJ, Clarke R, Hibbert J, Jones NS et al.
editors. Scott − Brown’s otolaryngology, head and neck surgery, 7th ed. London: Hodder Arnold 2008. pp. 3260–3275.
World Health Organization. Prevention of blindness and deafness: grades of hearing impairment. Geneva: World Health Organization 2014.
de Moraes Marchiori LL, de Almeida Rego Filho E, Matsuo T. Hypertension as a factor associated with hearing loss. Braz J Otorhinolaryngol 2006; 72:533–540.
Esparza CM, Jáuregui-Renaud K, Morelos CM, Muhl GE, Mendez MN, Carillo NS et al.
Systemic high blood pressure and inner ear dysfunction: a preliminary study. Clin Otolaryngol 2007; 32:173–178.
Chávez-Delgado ME, Vázquez-Granados I, Rosales-Cortés M, Velasco-Rodríguez V. Cochleovestibular dysfunction in patients with diabetes mellitus, hypertension, and dyslipidemia. Acta Otorrinolaringol Esp 2012; 63:93–101.
Gates GA, Cobb JL, D’Agostinho RB, Wolf A. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk Factors. Arch Otolaryngol Head Neck Surg 1993; 119:156–161.
Narlawar UW, Surjuse BG, Thakre SS. Hypertension and hearing impairment in workers of iron and steel industry. Indian J Physiol Pharmacol 2006; 50:60–66.
Shargorodsky J, Curhan SG, Eavey R, Curhan GC. A prospective study of cardiovascular risk factors and incident hearing loss in men. Laryngoscope 2010; 120:1887–1891.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]